Literature DB >> 6576751

Hypercalcaemia in association with renal failure: the role of immobilisation.

R L Prince, J A Eisman, R W Simpson.   

Abstract

Hypercalcaemia occurring after ten weeks of immobilisation was observed in four adult patients all of whom had had prior renal failure sufficient to require renal dialysis. In all patients parathyroid hormone levels were normal or low and in three plasma 1,25(OH)2D3 levels were low. These findings are consistent with immobilisation induced increases in bone calcium resorption. Renal excretion of calcium may have been impaired by renal dysfunction resulting in hypercalcaemia and suppression of plasma PTH and 1,25(OH)2D3 levels. Resolution of the hypercalcaemia was associated with remobilisation. Parathyroidectomy is inappropriate treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6576751     DOI: 10.1111/j.1445-5994.1983.tb04537.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  5 in total

1.  Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure.

Authors:  Michael P Whyte; Rattana Leelawattana; William R Reinus; Chang Yang; Steven Mumm; Deborah V Novack
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

2.  Immobilization and hypercalciuria in children.

Authors:  Fernando Korkes; André B Segal; Ita P Heilberg; Heloisa Cattini; Clóris Kessler; Cláudio Santili
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

3.  Bone scintigraphy of severe hypercalcemia following simvastatin induced rhabdomyolysis.

Authors:  Zubair B Mirza; Sophia Hu; Louis F Amorosa
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

4.  Severe hypercalcaemia four months after acute oliguric renal failure--successful treatment with intravenous clodronate.

Authors:  G Crowe; R Spedding; D R McCance; S J Rankin; A B Atkinson
Journal:  Ir J Med Sci       Date:  1992-06       Impact factor: 1.568

5.  Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure.

Authors:  Esther de Beus; Walther H Boer
Journal:  Clin Kidney J       Date:  2012-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.